591 related articles for article (PubMed ID: 34209981)
1. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
Malogolovkin A; Gasanov N; Egorov A; Weener M; Ivanov R; Karabelsky A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209981
[TBL] [Abstract][Full Text] [Related]
2. Current strategies of virotherapy in clinical trials for cancer treatment.
Lin W; Zhao Y; Zhong L
J Med Virol; 2021 Aug; 93(8):4668-4692. PubMed ID: 33738818
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
Rajani KR; Vile RG
Viruses; 2015 Nov; 7(11):5889-901. PubMed ID: 26580645
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viruses for cancer immunotherapy.
Hemminki O; Dos Santos JM; Hemminki A
J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option.
Ren Y; Miao JM; Wang YY; Fan Z; Kong XB; Yang L; Cheng G
Front Immunol; 2022; 13():961796. PubMed ID: 35911673
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
7. Viruses for tumor therapy.
Bell J; McFadden G
Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333
[TBL] [Abstract][Full Text] [Related]
8. A promising future in cancer immunotherapy: Oncolytic viruses.
Seyed-Khorrami SM; Azadi A; Rastegarvand N; Habibian A; Soleimanjahi H; Łos MJ
Eur J Pharmacol; 2023 Dec; 960():176063. PubMed ID: 37797673
[TBL] [Abstract][Full Text] [Related]
9. From virotherapy to oncolytic immunotherapy: where are we now?
Coffin RS
Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with oncolytic viruses and immune checkpoint inhibitors.
Chiu M; Armstrong EJL; Jennings V; Foo S; Crespo-Rodriguez E; Bozhanova G; Patin EC; McLaughlin M; Mansfield D; Baker G; Grove L; Pedersen M; Kyula J; Roulstone V; Wilkins A; McDonald F; Harrington K; Melcher A
Expert Opin Biol Ther; 2020 Jun; 20(6):635-652. PubMed ID: 32067509
[No Abstract] [Full Text] [Related]
11. Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials.
Hwang JK; Hong J; Yun CO
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207653
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
[TBL] [Abstract][Full Text] [Related]
13. Development of oncolytic virotherapy: from genetic modification to combination therapy.
Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
Suryawanshi YR; Schulze AJ
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
[TBL] [Abstract][Full Text] [Related]
15. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
16. Clinical Application of Oncolytic Viruses: A Systematic Review.
Cook M; Chauhan A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053757
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cejalvo JM; Falato C; Villanueva L; Tolosa P; González X; Pascal M; Canes J; Gavilá J; Manso L; Pascual T; Prat A; Salvador F
Cancer Treat Rev; 2022 May; 106():102392. PubMed ID: 35436729
[TBL] [Abstract][Full Text] [Related]
18. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.
Rojas JJ; Sampath P; Hou W; Thorne SH
Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615
[TBL] [Abstract][Full Text] [Related]
19. Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Farrera-Sal M; Moya-Borrego L; Bazan-Peregrino M; Alemany R
Clin Cancer Res; 2021 Jun; 27(11):2979-2988. PubMed ID: 33526422
[TBL] [Abstract][Full Text] [Related]
20. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]